ATE218349T1 - Neuartige zusammensetzung basierend auf einer synergistischen mischung von einem oder mehreren vrd-liganden und retinoiden - Google Patents

Neuartige zusammensetzung basierend auf einer synergistischen mischung von einem oder mehreren vrd-liganden und retinoiden

Info

Publication number
ATE218349T1
ATE218349T1 AT96931100T AT96931100T ATE218349T1 AT E218349 T1 ATE218349 T1 AT E218349T1 AT 96931100 T AT96931100 T AT 96931100T AT 96931100 T AT96931100 T AT 96931100T AT E218349 T1 ATE218349 T1 AT E218349T1
Authority
AT
Austria
Prior art keywords
ligands
retinoids
vrd
composition based
novel composition
Prior art date
Application number
AT96931100T
Other languages
English (en)
Inventor
Serge Michel
Veronique Dionisius-Pouget
Original Assignee
Galderma Rech Dermatologique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9482603&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE218349(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Galderma Rech Dermatologique filed Critical Galderma Rech Dermatologique
Application granted granted Critical
Publication of ATE218349T1 publication Critical patent/ATE218349T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
AT96931100T 1995-09-15 1996-09-10 Neuartige zusammensetzung basierend auf einer synergistischen mischung von einem oder mehreren vrd-liganden und retinoiden ATE218349T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9510854A FR2738745B1 (fr) 1995-09-15 1995-09-15 Nouvelles compositions a base d'un melange synergetique entre au moins un ligand de vdr et un retinoide, et leurs utilisations
PCT/FR1996/001386 WO1997009987A1 (fr) 1995-09-15 1996-09-10 Nouvelles compositions a base d'un melange synergetique entre au moins un ligand de vdr et un retinoide

Publications (1)

Publication Number Publication Date
ATE218349T1 true ATE218349T1 (de) 2002-06-15

Family

ID=9482603

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96931100T ATE218349T1 (de) 1995-09-15 1996-09-10 Neuartige zusammensetzung basierend auf einer synergistischen mischung von einem oder mehreren vrd-liganden und retinoiden

Country Status (14)

Country Link
US (1) US6759396B1 (de)
EP (1) EP0788361B1 (de)
JP (1) JP2898100B2 (de)
AT (1) ATE218349T1 (de)
AU (1) AU687687B2 (de)
BR (1) BR9606648B1 (de)
CA (1) CA2204437C (de)
DE (1) DE69621580T2 (de)
DK (1) DK0788361T3 (de)
ES (1) ES2181908T3 (de)
FR (1) FR2738745B1 (de)
NZ (1) NZ318430A (de)
PT (1) PT788361E (de)
WO (1) WO1997009987A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6538037B2 (en) * 1991-01-08 2003-03-25 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
US20010002396A1 (en) 1998-07-16 2001-05-31 Charles Achkar Compositions and methods of treating skin conditions
US6552009B2 (en) 1998-07-16 2003-04-22 Gentrix Llc Compositions and methods of treating abnormal cell proliferation
FR2804323B1 (fr) * 2000-01-31 2006-07-07 Galderma Res & Dev Utilisation de composes de type retinoides en tant qu'agents anti-bacteriens
DE10255861A1 (de) * 2002-11-29 2004-06-17 Axxima Pharmaceuticals Ag Gegen Hepatitis C-Virusinfektionen nützliche Verbindungen und Substanzen
JP4473491B2 (ja) * 2002-05-28 2010-06-02 株式会社資生堂 毛穴縮小剤
EP1687265A2 (de) * 2003-11-20 2006-08-09 Eli Lilly And Company Modulatoren des vitamin-d-rezeptors
WO2005051893A2 (en) * 2003-11-20 2005-06-09 Eli Lilly And Company Vitamin d receptor modulators
WO2005102296A2 (en) * 2004-04-23 2005-11-03 Heptagen Limited Combinations for the treatment of immunoproliferative skin disorders such as psoriasis
WO2005123090A1 (en) * 2004-06-17 2005-12-29 Galderma S.A. Composition in spray form comprising a combination of a corticoid and a vitamin d derivative in an oily phase
WO2005123092A1 (en) * 2004-06-17 2005-12-29 Galderma S.A. Composition for the treatment of psoriasis comprising a silicone agent, a corticosteroid and vitamin d or a derivative thereof
FR2871698B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques et une phase huileuse
WO2005123091A1 (en) * 2004-06-17 2005-12-29 Galderma S.A. Composition in the form of a spray comprising a combination of clobetasol propionate and calcitriol, an alcohol phase and an oily phase
FR2871695B1 (fr) 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un agent silicone et deux principes actifs solubilises
FR2871700B1 (fr) * 2004-06-17 2006-11-17 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse
WO2006133829A2 (de) * 2005-06-17 2006-12-21 Dsm Ip Assets B.V. Verwendung von 25-hydroxy-vitamin d3
US20100056644A1 (en) * 2006-11-29 2010-03-04 Nilendu Sen Pharmaceutical compositions containing anhydrous calcipotriene
CN103202821B (zh) * 2013-04-09 2014-10-01 青岛正大海尔制药有限公司 一种骨化三醇软胶囊及其制备方法
US10933018B2 (en) 2015-10-30 2021-03-02 Timber Pharmaceuticals Llc Isotretinoin formulations and uses and methods thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85849A1 (fr) * 1985-04-11 1986-11-05 Cird Derives benzonaphtaleniques,leur procede de preparation et leur application dans les domaines pharmaceutiques et cosmetiques
US5780676A (en) * 1992-04-22 1998-07-14 Ligand Pharmaceuticals Incorporated Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
FR2713640B1 (fr) * 1993-12-15 1996-01-05 Cird Galderma Nouveaux composés aromatiques polycycliques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
FR2713635B1 (fr) 1993-12-15 1996-01-05 Cird Galderma Nouveaux composés propynyl bi-aromatiques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
FR2733684B1 (fr) * 1995-05-03 1997-05-30 Cird Galderma Utilisation de retinoides dans une composition cosmetique ou pour la fabrication d'une composition pharmaceutique

Also Published As

Publication number Publication date
AU687687B2 (en) 1998-02-26
CA2204437A1 (fr) 1997-03-20
BR9606648A (pt) 1997-09-16
CA2204437C (fr) 2003-06-10
US6759396B1 (en) 2004-07-06
JPH10503533A (ja) 1998-03-31
DE69621580D1 (de) 2002-07-11
ES2181908T3 (es) 2003-03-01
BR9606648B1 (pt) 2009-01-13
EP0788361B1 (de) 2002-06-05
DE69621580T2 (de) 2003-03-13
MX9703461A (es) 1997-07-31
EP0788361A1 (de) 1997-08-13
AU6991296A (en) 1997-04-01
DK0788361T3 (da) 2002-07-15
NZ318430A (en) 2000-09-29
FR2738745A1 (fr) 1997-03-21
FR2738745B1 (fr) 1997-10-24
WO1997009987A1 (fr) 1997-03-20
JP2898100B2 (ja) 1999-05-31
PT788361E (pt) 2002-11-29

Similar Documents

Publication Publication Date Title
ATE218349T1 (de) Neuartige zusammensetzung basierend auf einer synergistischen mischung von einem oder mehreren vrd-liganden und retinoiden
ATE209477T1 (de) Minoxidil enthaltendes haarpflegemittel mit einem niedrigen gehalt an fettigem lösungsmittel
KR880010751A (ko) 피부보호 조성물
FR2544984B1 (fr) Pommade dermique et dermatologique a large spectre d'activite, et son procede de preparation
FR2710264B1 (fr) Utilisation pour le traitement des peaux mixtes d'une quantité efficace de substances actives.
FR2715845B1 (fr) Composition cosmétique et/ou dermatologique contenant du vinaigre.
DK431589A (da) Saarbehandlingsmidler indeholdende thromboxan a2-receptor-antagonister
DE69825333D1 (de) Verwendung von Polymer mit einer kritischer Temperatur von der LCST oder UCST-Type in und für die Herstellung von einer kosmetischen oder dermatologischen Zusammensetzung, sowie Zusammensetzungen diese enthaltend
ATE71831T1 (de) Kosmetische zusammensetzung fuer das haar.
ATE52911T1 (de) Topische anwendung des 3-phenylacetylamino-2,6piperidindionszur behandlung von hautfalten und hyperpigmentierung.
BR8502971A (pt) Composicoes cosmeticas que permitem retardar a aparicao do aspecto oleoso dos cabelos,utilizacao e processo para o tratamento dos cabelos
IT8848251A0 (it) Composti correlati all'acetozolammi de con attivita' inibitrice dell'anidrasi carbonica, utili in particolare nel trattamento del glaucoma
DE59506539D1 (de) Hydrogel für die applikation von therapeutischen und/oder kosmetischen wirkstoffen an die haut
ATE77048T1 (de) Bioemulgatoren enthaltende kosmetische und pharmazeutische zusammensetzungen.
AU571242B2 (en) Method of treating seborrheic dermatitis using a lithium containing composition
ATE137955T1 (de) Verwendung von 1,2-dipalmitoyl-l-alpha- phosphatidyl-n,n-dimethylethanilamine in dermatologischen und kosmetischen zusammensetzungen
ATE240110T1 (de) Verwendung von natriumchlorid zur behandlung der akne und/oder der rosacea
JPS55104205A (en) Cosmetics for skin
DE69618665D1 (de) Neuartige pflanzenextrakte, herstellungsmethode für dieselben sowie verwendung in kosmetika
DE59803222D1 (de) Kosmetische mittel
SE9002447L (sv) Foer hudlotioner, hudkraemer o.l. avsett koncentrat
MX9605223A (es) Composiciones cosmeticas.
TH18480A (th) วิธีการใช้ไดฟิลลีนสำหรับส่งเสริมการเจริญงอกงามของผม
DE69310332D1 (de) Anwendung von decahydropyrazino 2,3-b pyrazin zur Verminderung des Gehalts von freiem oder gebundenem Schwefelwasserstoff in einer Flüssigkeit
ES2008607A6 (es) Peine para el tratamiento del cabello.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification